What is IDEX's gross profit margin?

What is the revenue and EPS growth rate for IDEX year over year?

What does IDEX do and what are its main business segments?

What is IDEX's latest dividend and current dividend yield?

What guidance did IDEX's management provide for the next earnings period?

What were the key takeaways from IDEX’s earnings call?

What factors drove the changes in IDEX's revenue and profit?

What were the key takeaways from IDEX's earnings call?

- **HST Dominance**: 34% organic order growth in HST, driven by data centers and semiconductors, offset weakness in FMT/FSDP.
- **8020 Margin Boost**: HST margin expansion of 60 bps in Q4 and 50 bps expected in 2026, powered by cross-business collaboration.
- **Share Buybacks**: $75M/Q share repurchases planned, contingent on M&A activity.
- **Cautious 2026 Outlook**: 1%-2% organic growth reflects HST strength vs. flat/declining industrial markets.

**【CEO Summary Section】**
- **HST Segment Growth**: Organic orders in HST rose 34% YoY, driven by data center applications, semiconductor consumables, and space/defense. Revenue grew 5% YoY, with margin expansion of 60 basis points due to price/cost efficiency and productivity gains.
- **8020 Strategy Execution**: The 8020 playbook is driving cross-business collaboration, with examples like HST's Materials Processing Technologies leveraging shared facilities for data center cooling solutions. This strategy is expected to boost HST margins by 50 basis points in 2026.
- **New CFO Leadership**: Sean Gillen's arrival signals a focus on disciplined capital allocation, with plans to balance M&A, organic growth, and shareholder returns.

**【CFO Financial Commentary】**
- **Q4 2025 Results**: Organic revenue grew 1%, with HST outperforming FMT (1% growth) and FSDP (-5% growth). Adjusted EBITDA margin expanded 40 basis points to 26.1%, supported by cost savings and price/cost management.
- **Free Cash Flow**: Full-year free cash flow of $617 million (103% of adjusted net income) enabled $250 million in share buybacks and dividend payments.
- **2026 Outlook**: Guidance for 1%-2% organic growth reflects HST's momentum offset by flat/declining FMT and FSDP. Adjusted EPS is projected at $8.15-$8.35, up 3%-5% YoY, with a focus on margin expansion in HST and cost containment elsewhere.

**【Q&A Highlights】**
- **Macro Indicators Lag**: CEO Eric Ashleman noted that while PMI improved, rapid-replenishment businesses (e.g., FMT, FSDP) showed no demand inflection, with visibility limited to mid-quarter.
- **Data Center Contribution**: HST's 34% order growth included 50% from direct data center applications, with the remainder in adjacent markets like semiconductors and optical switching.
- **Capital Allocation**: CFO Sean Gillen emphasized a balanced approach, with $75M/Q share buybacks (if M&A activity is low) and bolt-on acquisitions to complement organic growth.
- **Margin Leverage**: HST's 50 basis point margin expansion in 2026 will come from volume growth and 8020-driven efficiency, while FMT/FSDP face headwinds from volume decrementals.

IDEX Corporation (IEX) Q4 2025 Earnings Call Transcript

- **Phase III Growth**: 5% organic revenue growth driven by HST (10%) and FMT (4%), with HST margin up 120bps. 
- **Cash Flow & Buybacks**: $189M free cash flow,2 $175M shares repurchased YTD. 
- **026 Outlook**: HST incrementals 35-40%, FMT 20-25%, FSDP 0-5%. 
- **Pricing & Savings**: 3.5% Q3 price realization, $60M+ annual savings. 
- **Strategic Focus**: Bolt-on M&A (e.g., Micro-Lam) and 8020-driven integration of growth platforms. 


**【CEO Summary Section】**
- IDEX is in Phase III of its evolution, focusing on high-growth markets like data centers, water solutions, and semiconductor MRO. 
- Q3 organic revenue grew 5%, driven by HST (10% growth). 
- HST% growth) and FMT (4 margin expanded 120bps due to volume leverage and cost savings. 
- FSDP faced softness in Fire & Safety and Dispensing, but FMT's intelligent water platform delivered strong municipal demand. 
- Company expects to deliver on 2025 guidance of $7.86-$7.91 EPS, with HST offsetting FSDP challenges. 

**【CFO Financial Commentary】**
- Q3 free cash flow: $189M (123% of adjusted net income). 
- Platform optimization and cost containment saved $17M, on track for $60M+ annual savings. 
- Share buybacks: $175M YTD, with $1B authorization. 
- Gross leverage: 2.1x, targeting under7.9 2.0x. 
- 2025 guidance narrowed to $7.86-$1 EPS, reflecting HST strength and FSDP headwinds. 

**【Q&A Highlights】**
- **Macro Environment**: CEO notes fragmented industrial demand, stable but no inflection. Data centers and water solutions show resilience. 
- **Order Visibility**: 50% booked at quarter start, limiting visibility. 
- **Government Funding**: European and Asian delays impact Fire & Safety, but US fire OEMs remain strong. 
- **2026 Outlook**: HST incrementals 35-40%, FMT 20-25%, FSDP 0-5%. 
- **Pricing**: 3.5% Q3 price realization, targeting 2%+ in 2026. 
- **M&A**: Focused on bolt-ons (e.g., Micro-Lam) to integrate with growth platforms. 
- **Margin Leverage**: 30-40% incremental margins across segments, higher in HST. 
- **Cost Savings**: $60M+ annual savings, with $42M structural and $18M discretionary. 
- **Share Repurchases**: Accelerated to $175M YTD, targeting 80%+ free cash flow return. 


IDEX Corporation (IEX) Q3 2025 Earnings Call Transcript

- **Revenue Growth**: 1% YoY, driven by pharma, energy, and agriculture, but tempered by semiconductor/automotive weakness.
- **Margin Challenges**: Adjusted EBITDA margin 27.4% (-40bps YoY) due to mix and Mott acquisition dilution.
- **Strategic Moves**: Acquired Micro-LAM to enhance optical capabilities; Mott nanofiltration solutions seeing growth in space/defense.
- **Guidance Adjustment**: Full-year EPS cut to $7.85-7.95, reflecting slower back-half growth from trade policy uncertainty.
- **Cash Flow Strength**: Free cash flow $147M (25% YoY growth), $100M share buybacks YTD.


**【CEO Summary Section】**
- **Q2 Performance**: Revenue growth of 1% YoY, driven by pharmaceutical, energy, and agriculture end markets. Adjusted EBITDA margin of 27.4%, down 40bps YoY due to mix and volume deleverage.
- **Trade Policy Impact**: Unpredictable shifts in trade policies caused order volatility, leading to a pause in customer decision-making for larger orders, particularly in semiconductor and automotive sectors.
- **Business Highlights**: 
  - **Airtech (HST)**: Growing faster by shifting focus to data center applications (fuel cell power support, liquid cooling), leveraging IDEX's global capabilities.
  - **Mott (HST)**: Nanofiltration solutions seeing growth in space/defense and high-purity semiconductor applications, but delayed orders due to policy uncertainty.
  - **Optical Technologies (HST)**: Acquired Micro-LAM to enhance precision optics capabilities, complementing existing coating and assembly expertise.
- **Guidance Adjustment**: Full-year organic sales growth revised to 1% (from 1-3%), adjusted EPS to $7.85-7.95 (from $8.10-8.45), reflecting slower back-half growth.

**【CFO Financial Commentary】**
- **Q2 Financials**: 
  - Organic orders +2%, organic sales +1% YoY.
  - Adjusted gross margin down 10bps YoY (27.4%), driven by Mott acquisition dilution and mix.
  - Free cash flow $147M (25% YoY growth), liquidity $1.1B.
  - Share buybacks $100M YTD, dividend $106M.
- **Cost Actions**: 
  - Platform optimization/delayering initiatives delivered $14M savings Q2, tracking to $62M annualized.
  - Cost containment efforts ($20M) offset volume-related risks.
- **Tariff Mitigation**: 2025 tariff impact $50M, fully offset via pricing and supply chain adjustments.

**【Q&A Key Highlights】**
- **Semiconductor Exposure**: High-margin lithography business (Muon) flattish due to inventory timing, but metrology optics growth offsetting.
- **Mott Growth**: Expected Q4 acceleration, but back-half growth tempered by delayed orders.
- **M&A Strategy**: Focused on tuck-ins (e.g., Micro-LAM) to expand MSS platform capabilities, targeting accretive returns.
- **Water Market**: Q2 weakness due to timing, but strong fundamentals and July recovery suggest steady growth.
- **China Exposure**: ~6% of revenue, pressured but offset by India growth.
- **Tariff Volatility**: Ongoing risk, but pricing strategies maintain margin resilience.


IDEX Corporation (IEX) Q2 2025 Earnings Call Transcript

- **Q1 Beat with Record Orders**: Organic orders up 4% YoY, driven by advantaged markets like space, defense, and municipal water.
- **Profitability Resilience**: Adjusted EBITDA margin 25.5% despite headwinds; adjusted EPS $1.75 (+$0.10 vs. high end of guidance).
- **$80M Cost Savings**: Proactive measures to offset potential demand softness from trade uncertainty.
- **Tariff Mitigation**: 5-6% COGS inflation fully offset by 3-4% price increases.

**【CEO Opening Remarks】**
- Q1 2025 revenue and profitability exceeded expectations across all segments.
- Organic orders rose 1% sequentially and 4% YoY to record levels, driven by space, defense, municipal water, and North American fire & safety.
- Proactive $20M cost-saving initiatives for 2025 (total $80M when combined with prior measures) to offset potential trade-related demand softness.
- Mott acquisition on track, with $40M multiyear wastewater filtration deal booked in Q1.

**【CFO Financial Highlights】**
- Q1 2025: 
  - Organic sales -1% YoY, but +1% in orders and +$60M in backlog.
  - Adjusted EBITDA margin 25.5% (-50bps YoY due to volume deleverage and Mott dilution).
  - Adjusted EPS $1.75 (vs. $1.65 guidance), driven by better-than-expected margins and $91M free cash flow.
  - $50M share buybacks; $490M remaining under current authorization.
- FY25 Guidance: 
  - Organic growth 1-3%, adjusted EPS $8.10-$8.45.
  - Tariffs expected to add 5-6% COGS inflation, fully mitigated by 3-4% price increases.
  - Q2 2025: flat to +2% organic growth, EBITDA margin 26.5-27% (+100bps vs. Q1).

IDEX (IEX)-1 May 25-2025 Q1 Earnings call transcript

- **Q4 Strong Finish**: $863M sales (+9%), $2.04 EPS beat, $157M free cash flow. HST projects drove 80% of Q4 growth.
- **2025 Growth Outlook**: 1-3% organic growth, $8.10-$8.45 EPS. HST leads with pharma, satellite, and energy transition tailwinds.
- **Q1 Challenges**: 3-4% organic decline due to project timing, semi cyclicality, and $0.20 EPS comp headwind.
- **Margin Expansion**: $0.43 EPS from platform optimization, offsetting $0.29 headwinds. 2025 EBITDA margin 27.5-28%.
- **Strategic Integration**: 50% of revenue in collaborative groups, leveraging scale in AI, IoT, and energy transition.


**【CEO Summary Section】**
- **Strong 2024 Execution**: Delivered $3.3B revenue with HST and FSDP segments driving organic growth. Mott acquisition integration ahead of schedule, contributing $40M in Q4 projects.
- **2025 Growth Drivers**: HST expected to lead with 1-3% organic growth, fueled by pharma, satellite comms, and energy transition. FSDP automation programs exceed 10% of revenue.
- **Strategic Integration**: 50% of revenue now in collaborative groups (e.g., HST, FSDP) leveraging scale and thematic megatrends like AI, IoT, and energy transition.
- **Margin Expansion**: $0.43 EPS accretion from platform optimization and delayering, offsetting $0.29 headwinds from variable comp reset and tax rate increase.

**【CFO Financial Commentary】**
- **Q4 Financials**: 
  - Orders: $817M (+8% reported, +5% organic)
  - Sales: $863M (+9% reported, +3% organic)
  - Adjusted EPS: $2.04 (+11% YoY)
  - Free Cash Flow: $157M (101% of adjusted net income)
- **2025 Guidance**: 
  - Organic Growth: 1-3% (HST at high end, FMT at low end)
  - Adjusted EPS: $8.10-$8.45 (+3-7% YoY)
  - EBITDA Margin: 27.5-28%
  - Key Drivers: Price/cost spread (60-80bps), productivity ($0.15-0.25 EPS), Mott accretion.
- **Q1 2025 Challenges**: 
  - Organic decline 3-4% due to project timing (HST $40M Q4 shipments) and semi market cyclicality.
  - Share-based comp headwind of $0.20 EPS.

**【Q&A Highlights】**
- **Project Timing Clarity**: Q4 $40M HST projects (80% pneumatic systems) won't repeat in Q1, contributing $0.22 sequential EPS decline.
- **Semi Market Outlook**: Sealing Solutions MRO growth (+Q4/Q1) signals utilization recovery, but capital equipment delays expected until H2.
- **Tariff Mitigation**: Localized supply chains and long customer relationships provide pricing resilience.
- **M&A Pipeline**: $10B+ pipeline focused on proprietary deals in HST and FMT, maintaining 80% proprietary transaction rate.
- **HST Recovery**: Life sciences fluidics and optical filters expected to grow 1-3%, offsetting genomics funding uncertainty.


Actual											1.33	1.1	1.4	1.37	1.51	1.61	1.63	1.71	1.96	2.02	2.14	2.01	2.09	2.18	2.12	1.83	1.88	2.06	1.9	2.04	1.75	2.07	2.03	2.1
Forecast											1.2981	0.9731	1.2007	1.3107	1.4147	1.6152	1.5945	1.5931	1.7432	1.8917	2.0032	1.9724	2.0231	2.1205	1.8848	1.7771	1.7571	2.042	1.8873	2.0218	1.6407	1.99	1.9303	2.0413
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+2.46%	+13.04%	+16.60%	+4.52%	+6.74%	-0.32%	+2.23%	+7.34%	+12.44%	+6.78%	+6.83%	+1.91%	+3.31%	+2.81%	+12.48%	+2.98%	+6.99%	+0.88%	+0.67%	+0.90%	+6.66%	+4.02%	+5.17%	+2.88%

IEX

IEX fundamentals

IEX Q4 2025 Earnings

Earnings Call

You can ask Aime

IEX

IEX fundamentals

IEX Q4 2025 Earnings

Earnings Call

IEX Earnings Call Summary for Q4/20259:00 AM on Feb 4, 2026

IEX Earnings Call Summary for Q3/20259:00 AM on Oct 29, 2025

IEX Earnings Call Summary for Q2/20259:00 AM on Jul 30, 2025

IEX Earnings Call Summary for Q1/20259:00 AM on May 1, 2025

IEX Earnings Call Summary for Q4/202410:30 AM on Feb 5, 2025

You can ask Aime